The prognostic role of BCL6 RNA and protein expression, as well as its mutational status in CLL, have been investigated over the years with conflicting reports [54,62,63], possibly resulting from differences in cell types tested and variations in the technologies deployed [17,63,64,65]. The gene discussed is BCL6; the disease is B-cell chronic lymphocytic leukemia.